•
Led successful US FDA Cosmetic Facility Registrations under MOCRA 2022, managing submissions for over 25 facilities, ensuring 100% compliance and timely approvals for USA market entry
•
Developed and implemented comprehensive formula and label review processes aligned with US FDA and California regulations, reducing non-compliance risks by 30% and enhancing product safety and marketing accuracy
•
Directed OTC drug regulatory submissions, including establishment registrations and product listings for sunscreens, achieving full compliance with FDA monographs and expediting market launch by 20%
•
Spearheaded EU Cosmetics Regulation 1223/2009 compliance initiatives, overseeing safety assessments, PIF and CPSR documentation for 40+ products, resulting in zero regulatory rejections and streamlined CPNP/SCNP notifications
•
Managed cross-functional teams to monitor evolving global regulatory landscapes (FDA, EU, REACH, EPA), providing strategic guidance that improved regulatory adherence and reduced audit findings by 25%
•
Championed label and claims reviews for EU and UK markets, aligning marketing communications with Article 19 requirements, which increased customer trust and minimized legal risks
•
Orchestrated pre-market regulatory plans and technical documentation for new product developments, accelerating approval timelines by 15% and supporting successful product commercialization
•
Established robust quality management and compliance frameworks, enhancing internal regulatory training and ensuring continuous alignment with international standards and best practices